Seer to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Core Viewpoint - Seer, Inc. will report its financial results for Q4 and full year 2025 on February 26, 2026, with a conference call scheduled for 1:30 p.m. Pacific Time [1] Company Overview - Seer is a life sciences company focused on developing transformative products that provide deep, unbiased proteomic insights [3] - The Proteograph™ Product Suite is an integrated solution that includes engineered nanoparticles, consumables, automation instrumentation, and software for large-scale proteomic analysis [3] - The Proteograph workflow is designed to be efficient and user-friendly, allowing for incorporation into nearly any laboratory setting [3] - The Proteograph Product Suite is intended for research use only and is not meant for diagnostic procedures [3]